arrow
R

Rezika Mohammed

University of Antwerp
H指数:22
被引数:1,618

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prediction of visceral leishmaniasis development in a highly exposed HIV cohort in Ethiopia based on Leishmania infection markers: results from the PreLeisH study

根据利什曼原虫感染标志物预测埃塞俄比亚高度暴露的HIV队列中的内脏利什曼病发展: PreLeisH研究的结果

2024-12-010
PRE
A preliminary indication that HLA-A*03:01 may be associated with visceral leishmaniasis development in people living with HIV in Ethiopia

初步迹象表明,hla-a * 03:01可能与埃塞俄比亚HIV感染者的内脏利什曼病发展有关。

2024-09-300
OAAI
Persistent T cell unresponsiveness associated with chronic visceral leishmaniasis in HIV-coinfected patients

HIV合并感染患者中与慢性内脏利什曼病相关的持续性T细胞无反应性

2024-05-033
OAAI
Genomic analysis of Plasmodium vivax describes patterns of connectivity and putative drivers of adaptation in Ethiopia
2023-11-272
OAAI
A molecular barcode and web-based data analysis tool to identify imported Plasmodium vivax malaria
2022-12-2310
OAAI
Paromomycin and Miltefosine Combination as an Alternative to Treat Patients With Visceral Leishmaniasis in Eastern Africa: A Randomized, Controlled, Multicountry Trial

巴龙霉素和米替福新联合作为治疗东非内脏利什曼病患者的替代方案: 一项随机,对照,多国试验

2022-09-2731
OAAI
Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria
2019-01-17185
OAAI
Long-term Clinical Outcomes in Visceral Leishmaniasis/Human Immunodeficiency Virus-Coinfected Patients During and After Pentamidine Secondary Prophylaxis in Ethiopia: A Single-Arm Clinical Trial
2017-09-1326
OAAI
Use of Pentamidine As Secondary Prophylaxis to Prevent Visceral Leishmaniasis Relapse in HIV Infected Patients, the First Twelve Months of a Prospective Cohort Study
2015-10-0251
OAAI